{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicz6lgwqk3po35qwxd5ft7ev62y5pi7pfzqlkm5i43dswpkihgwmu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnd7v2sidrf2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicvq33n2ux4avucxasnvz4qyva6drmqq2x5hjvs3vrx5zn4wy2j6u"
    },
    "mimeType": "image/jpeg",
    "size": 247274
  },
  "path": "/news/2026-06-prostate-cancer-treatment-disease-clinical.html",
  "publishedAt": "2026-06-02T13:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer Institute and professor of internal medicine at the University of Utah (the U), has found that a combination prostate cancer treatment could prevent the disease from progressing into a harder-to-treat form of cancer in select patients.",
  "title": "Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows"
}